ASH Annual Meeting

ASH Annual Meeting

Interviews from the American Society of Hematology’s Annual Meeting

video

Samir K. Ballas, MD: Sickle Cell Patients Are Innocent Victims of the Opioid Epidemic

Patients with sickle cell disease (SCD) often take opioids to manage their pain, but use has not skyrocketed in the current opioid epidemic. Dr....
video

Daniel DeAngelo, MD, PhD: BLU-285 Active, Well-Tolerated in Advanced Systemic Mastocytosis

Dr. DeAngelo discusses results from the phase I study presented as a plenary abstract at this year's meeting, evaluating the KIT inhibitor BLU-285 in...
video

Mikkael A. Sekeres, MD, MS: Highlights of the 2017 ASH Annual Meeting

ASH Clinical News Editor-in-Chief Mikkael A. Sekeres, MD, MS, shares some “must-see” sessions at the 2017 ASH Annual Meeting.
video

Stephen M. Ansell, MD, PhD: Nivolumab Moves to Hematology

Dr. Ansell, a speaker in the Special Education Session on Newly Approved Drugs, discusses the growing role of nivolumab in hematologic malignancies.
video

Eugenia Vicky Asare, MD: Multidisciplinary Care Saves Lives Among Pregnant Women with SCD in...

Dr. Asare shares how instituting simple protocols and a multidisciplinary approach dramatically reduced the mortality rate of pregnant women with sickle cell disease living...
video

Sherrill J. Schlicter, MD: Prolonging Platelet Shelf-Life With DMSO

Transfusion with cryopreserved platelets may offer superior bleeding control for thrombocytopenic patients. Dr. Schlicter shares results from a phase I study, and gives a...
video

Steven Pipe, MD: Changing the Delivery of Bleeding Prevention for Hemophilia Patients

Dr. Pipe, a speaker in the Special Education Session on Newly Approved Drugs, reviews what clinicians need to know about coagulation factor IX (recombinant)/antihemophilic...
video

Alexander Perl, MD: The New FLT3 Inhibitor Gilteritinib is “Well-Tolerated” in AML

Dr. Perl discusses results from the phase I CHRYSALIS trial, which investigated gilteritinitib in patients with relapsed/refractory acute myeloid leukemia.
video

Crystal Mackall, MD: Passing the Checkpoint With New Approaches to Immunotherapy

Checkpoint blockade is revolutionizing immunotherapy, but there is room for improvement. Dr. Mackall, who chaired a session on “Novel Approaches to Immunotherapy,” speaks about...
video

Sherrill J. Schlicter, MD: Prolonging Platelet Shelf-Life With DMSO

Transfusion with cryopreserved platelets may offer superior bleeding control for thrombocytopenic patients. Dr. Schlicter shares results from a phase I study, and gives a...
Advertisement

Current Issue

September 2019 Volume 5 Issue 11

September 2019, Volume 5, Issue 11

This issue explores politics in the exam room, demystifies proteomic analysis in hematology, and more.